Literature DB >> 16515887

History of adenomyosis.

Giuseppe Benagiano1, Ivo Brosens.   

Abstract

Although the claim has been made that there are early descriptions of what today we call endometriosis and adenomyosis in theses presented in Europe in the late 17(th) and during the 18(th) centuries, the first description of the condition initially named 'adenomyoma' is that provided in 1860 by the German pathologist Carl von Rokitansky, who found endometrial glands in the myometrium and designated this finding as 'cystosarcoma adenoids uterinum'. Over the following 50 years 'adenomyoma' (and endometriosis) were considered pathologies separate from the so-called 'haemorrhagic ovarian cysts', and it was not until 1921 that this condition was recognized to be of endometriotic origin. The first systematic description of what is today known as adenomyosis was the work of Thomas Stephen Cullen who, at the turn of the 19(th) century, fully researched the 'mucosal invasion' already observed by a number of investigators in several parts of the lower abdominal cavity. Cullen clearly identified the epithelial tissue invasion as being made of 'uterine mucosa' and defined the mechanism through which the mucosa invades the underlying tissue. In 1925, 2 years before Sampson created the term 'endometriosis', Frankl created a name for the mucosal invasion of the myometrium and clearly described its anatomical picture; he called it 'adenomyosis uteri' and explained that 'I have chosen the name of adenomyosis, which does not suggest any inflammatory genesis as do terms like adenometritis, adenomyositis, adenomyometritis, still employed'. The current definition of adenomyosis was finally provided in 1972 by Bird who stated: 'Adenomyosis may be defined as the benign invasion of endometrium into the myometrium, producing a diffusely enlarged uterus which microscopically exhibits ectopic non-neoplastic, endometrial glands and stroma surrounded by the hypertrophic and hyperplastic myometrium'.

Entities:  

Mesh:

Year:  2006        PMID: 16515887     DOI: 10.1016/j.bpobgyn.2006.01.007

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN: 1521-6934            Impact factor:   5.237


  29 in total

1.  Inflammatory cytokines differentially up-regulate human endometrial haptoglobin production in women with endometriosis.

Authors:  K L Sharpe-Timms; H Nabli; R L Zimmer; J A Birt; J W Davis
Journal:  Hum Reprod       Date:  2010-02-22       Impact factor: 6.918

2.  Looking for an effective and non-invasive diagnostic test for endometriosis: where are we?

Authors:  Pietro G Signorile; Alfonso Baldi
Journal:  Ann Transl Med       Date:  2018-12

3.  Evaluation of miR-135a/b expression in endometriosis lesions.

Authors:  Rafaella Petracco; Ana Cristina De Oliveira Dias; Hugh Taylor; Álvaro Petracco; Mariângela Badalotti; João Da Rosa Michelon; Daniel Rodrigo Marinowic; Marta Hentschke; Pamella Nunes De Azevedo; Gabriele Zanirati; Denise Cantarelli Machado
Journal:  Biomed Rep       Date:  2019-09-02

4.  The Role of Adenomyosis in the Pathogenesis of Preeclampsia.

Authors:  P S Hasdemir; M Farasat; C Aydin; B C Ozyurt; T Guvenal; G Pekindil
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-08       Impact factor: 2.915

5.  Endometriosis for the colorectal surgeon.

Authors:  Katrina Slaughter; Rajiv B Gala
Journal:  Clin Colon Rectal Surg       Date:  2010-06

Review 6.  Rectal mucosal endometriosis primarily misinterpreted as adenocarcinoma: a case report and review of literature.

Authors:  Hui Chen; Qiuping Luo; Shaoyan Liu; Hanzhen Xiong; Qingping Jiang
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

7.  Archimetrosis: the evolution of a disease and its extant presentation : Pathogenesis and pathophysiology of archimetrosis (uterine adenomyosis and endometriosis).

Authors:  Gerhard Leyendecker; Ludwig Wildt; Matthias W Laschke; Gerhard Mall
Journal:  Arch Gynecol Obstet       Date:  2022-05-21       Impact factor: 2.344

8.  Endometriosis: A Retrospective Analysis of Clinical Data from a Cohort of 4,083 Patients, With Focus on Symptoms.

Authors:  Pietro G Signorile; Maria Cassano; Rosa Viceconte; Valentina Marcattilj; Alfonso Baldi
Journal:  In Vivo       Date:  2022 Mar-Apr       Impact factor: 2.155

9.  Perioperative Suppression of Schwann Cell Dedifferentiation Reduces the Risk of Adenomyosis Resulting from Endometrial-Myometrial Interface Disruption in Mice.

Authors:  Xi Wang; Xishi Liu; Sun-Wei Guo
Journal:  Biomedicines       Date:  2022-05-24

10.  Adenomyosis: Epidemiology, Risk Factors, Clinical Phenotype and Surgical and Interventional Alternatives to Hysterectomy.

Authors:  F A Taran; E A Stewart; S Brucker
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-09       Impact factor: 2.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.